These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6988805)

  • 21. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolic effects of oral contraceptives: influence of the dosage and nature of the substance used].
    Basdevant A
    Contracept Fertil Sex (Paris); 1979 Nov; 4(11):781-5. PubMed ID: 12261846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative enhancement of dinitrochlorobenzene responsivity in women receiving oral contraceptives.
    Rea TH
    Arch Dermatol; 1979 Mar; 115(3):361-2. PubMed ID: 434857
    [No Abstract]   [Full Text] [Related]  

  • 24. Calciumantagonistic effect of natural and synthetic estrogens--investigations on a nongenomic mechanism of direct vascular action.
    Mueck AO; Seeger H; Lippert TH
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):424-6. PubMed ID: 8897079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choosing the appropriate oral contraceptive.
    Langer A; Devanesan M; Pelosi MA
    Drug Ther (NY); 1978 Jun; 8(7):112-20. PubMed ID: 12260696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular lesions and thromboembolic vascular occlusions following oral contraceptives].
    Pesendorfer F; Platthy G
    Med Klin; 1973 Jan; 68(3):74-7. PubMed ID: 4685190
    [No Abstract]   [Full Text] [Related]  

  • 27. Intimal vascular lesions associated with female reproductive steroids.
    Irey NS; Norris HJ
    Arch Pathol; 1973 Oct; 96(4):227-34. PubMed ID: 4743889
    [No Abstract]   [Full Text] [Related]  

  • 28. [Transitory ischemic attacks, migraine and progestogen drugs. Etiopathogenetic correlations].
    Moretti G; Manzoni GC; Carpeggiani P; Parma M
    Minerva Med; 1980 Aug; 71(30):2125-9. PubMed ID: 7432644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vascular thrombosis in synthetic estrogen-progestogen users: an immune mechanism (author's transl)].
    Beaumont V; Beaumont JL
    Nouv Presse Med; 1981 Feb; 10(7):503-7. PubMed ID: 7232196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etiology of shock lung: case report (author's transl)].
    Benke A; Kosak D; Platthy G
    Med Klin; 1976 Oct; 71(42):1775-9. PubMed ID: 979877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dermatological complications caused by oral contraceptives].
    Deharo C; Berbis P; Privat Y
    Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The contraceptive pill and vascular accidents].
    Lancet M
    Harefuah; 1983 Feb; 104(3):107-8. PubMed ID: 6618293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of combined contraceptive tablets on blood levels of the gonadotropic hormones estradiol and progesterone (author's transl)].
    Balogh A; Ditroi F; Batar I; Lampe L
    Orvoskepzes; 1981; 56(3):220-8. PubMed ID: 12338270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current concepts of the effect of contraceptives on the oral cavity and especially on the periodontal tissues].
    Tsami-Pandi A; Diamanti-Kipioti A
    Hell Stomatol Chron; 1984; 28(3):149-54. PubMed ID: 6399510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drugs with unwanted side-effects on the retinal vessels (author's transl)].
    Gnad HD
    Klin Monbl Augenheilkd; 1975 Oct; 167(4):604-7. PubMed ID: 1206943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Venous complications caused by estroprogestative treatment at the Strasbourg University Maternity Hospital].
    Muller P; Dellenbach P
    Phlebologie; 1972; 25(3):256-7. PubMed ID: 4662050
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of endothelin receptor antagonism in collar-induced intimal thickening and vascular reactivity changes in rabbits.
    Reel B; Ozkal S; Islekel H; Ozer E; Oktay G; Sozer GO; Tanriverdi S; Turkseven S; Kerry Z
    J Pharm Pharmacol; 2005 Dec; 57(12):1599-608. PubMed ID: 16354404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.